Table 1.
Gene SNP1 | Genotype SNP1 | Gene SNP2 | Genotype SNP2 | Population set | OR | OR L95 | OR U95 | P | Se | Pe | Freq. Cases | Freq. Controls | a | b | c | d | N |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BANK1 | BLK | ||||||||||||||||
rs10516483 | CC | rs1478895 | CC | North Europe 100k | 2.38 | 1.69 | 3.36 | 4.83E-07 | 8.9 | 0.0001 | 35% | 18% | 88 | 167 | 92 | 416 | 763 |
Set 1 (USA) | - | - | - | - | - | - | - | - | - | - | - | ||||||
Set 2 (Europe) | 1.42 | 1.17 | 1.72 | 0.0003 | −0.3 | 0.8256 | 25% | 19% | 261 | 773 | 285 | 1200 | 2519 | ||||
Meta-analysis b | 1.60 | 1.36 | 1.89 | 7.61E-12 | nc | 349 | 940 | 377 | 1616 | 3282 | |||||||
rs10516487 | GG | rs1478895 | CC | North Europe 100k | 1.82 | 1.35 | 2.45 | 8.27E-05 | 3.7 | 0.0063 | 48% | 33% | 131 | 144 | 171 | 342 | 788 |
Set 1 (USA) | 1.33 | 1.06 | 1.66 | 0.0124 | 2.7 | 0.0170 | 38% | 31% | 233 | 388 | 241 | 533 | 1395 | ||||
Set 2 (Europe) | 1.33 | 1.13 | 1.57 | 0.0005 | −1.0 | 0.9578 | 42% | 35% | 434 | 605 | 527 | 980 | 2546 | ||||
Meta-analysis a | 1.40 | 1.24 | 1.58 | 1.97E-10 | nc | 798 | 1137 | 939 | 1855 | 4729 | |||||||
rs10516483 | CC | rs2736340 | TT+TC | North Europe 100k | 2.32 | 1.44 | 3.76 | 4.68E-04 | 4.6 | 0.0111 | 24% | 12% | 56 | 178 | 31 | 229 | 494 |
Set 1 (USA) | - | - | - | - | - | - | - | - | - | ||||||||
Set 2 (Europe) | 1.70 | 1.36 | 2.13 | 3.65E-06 | 6.3 | 0.0024 | 18% | 12% | 184 | 824 | 169 | 1287 | 2464 | ||||
Meta-analysis b | 1.80 | 1.47 | 2.21 | 1.18E-11 | nc | 19% | 12% | 240 | 1002 | 200 | 1516 | 2958 | |||||
rs10516487 | GG | rs2736340 | TT+TC | North Europe 100k | 1.82 | 1.22 | 2.72 | 0.0031 | 2.6 | 0.0373 | 32% | 21% | 80 | 170 | 54 | 209 | 513 |
Set 1 (USA) | 1.57 | 1.22 | 2.02 | 4.36E-04 | −1.6 | 0.9850 | 27% | 19% | 168 | 453 | 148 | 626 | 1395 | ||||
Set 2 (Europe) | 1.62 | 1.34 | 1.95 | 3.55E-07 | 6.7 | 0.0013 | 29% | 20% | 293 | 720 | 297 | 1181 | 2491 | ||||
Meta-analysis a | 1.63 | 1.41 | 1.87 | 1.75E-15 | nc | 29% | 20% | 541 | 1343 | 499 | 2016 | 4399 | |||||
| |||||||||||||||||
BANK1 | GG | rs10516487 | Meta-analysis a | 1.37 | 1.22 | 1.54 | 4.33E-08 | 56% | 48% | 4791 | |||||||
CC | rs10516483 | Meta-analysis b | 1.52 | 1.31 | 1.76 | 1.66E-12 | 36% | 27% | 3334 | ||||||||
BLK | TT+TC | rs2736340 | Meta-analysis a | 1.33 | 1.21 | 1.46 | 4.31E-14 | 30% | 24% | 8862 |
The epistasis P value (Pe) measures only the statistical significance of the epistatic effect of the interaction. For every 2 SNP-genotype combination tested, a contingency table under the null hypothesis of independence between both SNPs (no epistasis) is derived and an expected Pearson S score is calculated (S0). The epistatic score is then defined as Se = S − S0. This score is the difference of two dependent scores, each one following asymptotically a one-degree of freedom chi-square distribution. Pe are empirically determined by permutations (100,000 case/control label shuffling). nc: Due to the nature of the Pe statistic, no permutation p-value can be calculated for meta-analysis.
North Europe 100k: discovery set, genotype data extracted from a 100.000 SNPs genome-wide scan in Swedish. The SNP rs2736340 was genotyped a posteriori. Replication Set 1 (USA): European-American set. Replication Set 2 (Europe): A combined set of German, Italian, European-Argentine and Spanish cases and controls.
a = cases with genotype SNP1 AND genotype SNP2, b = cases with other genotype, c = controls with genotype SNP1 AND genotype SNP2, d = controls with other genotype. N: number of cases and controls with non-missing genotypes for both SNP 1 and SNP 2. Frequencies of the 2 SNP-genotype combinations in cases and controls are shown.